These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32700443)

  • 1. Embedding Ethical Impact Assessment in Nanosafety Decision Support.
    Malsch I; Isigonis P; Dusinska M; Bouman EA
    Small; 2020 Sep; 16(36):e2002901. PubMed ID: 32700443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing ethical impact assessment for nano risk governance.
    Malsch I; Isigonis P; Bouman E; Afantitis A; Melagraki G; Dusinska M
    Open Res Eur; 2023; 3():170. PubMed ID: 38947422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAIRification of nanosafety data to improve applicability of (Q)SAR approaches: A case study on
    Bossa C; Andreoli C; Bakker M; Barone F; De Angelis I; Jeliazkova N; Nymark P; Battistelli CL
    Comput Toxicol; 2021 Nov; 20():100190. PubMed ID: 34820591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials.
    Isigonis P; Afantitis A; Antunes D; Bartonova A; Beitollahi A; Bohmer N; Bouman E; Chaudhry Q; Cimpan MR; Cimpan E; Doak S; Dupin D; Fedrigo D; Fessard V; Gromelski M; Gutleb AC; Halappanavar S; Hoet P; Jeliazkova N; Jomini S; Lindner S; Linkov I; Longhin EM; Lynch I; Malsch I; Marcomini A; Mariussen E; de la Fuente JM; Melagraki G; Murphy F; Neaves M; Packroff R; Pfuhler S; Puzyn T; Rahman Q; Pran ER; Semenzin E; Serchi T; Steinbach C; Trump B; Vrček IV; Warheit D; Wiesner MR; Willighagen E; Dusinska M
    Small; 2020 Sep; 16(36):e2003303. PubMed ID: 32700469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What can nanosafety learn from drug development? The feasibility of "safety by design".
    Hjorth R; van Hove L; Wickson F
    Nanotoxicology; 2017 Apr; 11(3):305-312. PubMed ID: 28303735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a more effective and efficient governance and regulation of nanomaterials.
    Teunenbroek TV; Baker J; Dijkzeul A
    Part Fibre Toxicol; 2017 Dec; 14(1):54. PubMed ID: 29258600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Occupational Risk Prevention of Nanomaterials Manufactured in Construction Sites in the EU.
    López-Alonso M; Díaz-Soler B; Martínez-Rojas M; Fito-López C; Martínez-Aires MD
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology.
    Marcoulaki E; López de Ipiña JM; Vercauteren S; Bouillard J; Himly M; Lynch I; Witters H; Shandilya N; van Duuren-Stuurman B; Kunz V; Unger WES; Hodoroaba VD; Bard D; Evans G; Jensen KA; Pilou M; Viitanen AK; Bochon A; Duschl A; Geppert M; Persson K; Cotgreave I; Niga P; Gini M; Eleftheriadis K; Scalbi S; Caillard B; Arevalillo A; Frejafon E; Aguerre-Chariol O; Dulio V
    NanoImpact; 2021 Jul; 23():100337. PubMed ID: 35559838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.
    Som C; Nowack B; Krug HF; Wick P
    Acc Chem Res; 2013 Mar; 46(3):863-72. PubMed ID: 23110540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a Glance.
    Zielińska A; Costa B; Ferreira MV; Miguéis D; Louros JMS; Durazzo A; Lucarini M; Eder P; Chaud MV; Morsink M; Willemen N; Severino P; Santini A; Souto EB
    Int J Environ Res Public Health; 2020 Jun; 17(13):. PubMed ID: 32605255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies.
    Doak SH; Clift MJD; Costa A; Delmaar C; Gosens I; Halappanavar S; Kelly S; Pejinenburg WJGM; Rothen-Rutishauser B; Schins RPF; Stone V; Tran L; Vijver MG; Vogel U; Wohlleben W; Cassee FR
    Small; 2022 Apr; 18(17):e2200231. PubMed ID: 35324067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical and scientific issues of nanotechnology in the workplace.
    Schulte PA; Salamanca-Buentello F
    Environ Health Perspect; 2007 Jan; 115(1):5-12. PubMed ID: 17366812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multi-facets of sustainable nanotechnology - Lessons from a nanosafety symposium.
    George S; Ho SS; Wong ES; Tan TT; Verma NK; Aitken RJ; Riediker M; Cummings C; Yu L; Wang ZM; Zink D; Ng Z; Loo SC; Ng KW
    Nanotoxicology; 2015 May; 9(3):404-6. PubMed ID: 25976321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards harmonisation of testing of nanomaterials for EU regulatory requirements on chemical safety - A proposal for further actions.
    Bleeker EAJ; Swart E; Braakhuis H; Fernández Cruz ML; Friedrichs S; Gosens I; Herzberg F; Jensen KA; von der Kammer F; Kettelarij JAB; Navas JM; Rasmussen K; Schwirn K; Visser M
    Regul Toxicol Pharmacol; 2023 Mar; 139():105360. PubMed ID: 36804527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key principles and operational practices for improved nanotechnology environmental exposure assessment.
    Svendsen C; Walker LA; Matzke M; Lahive E; Harrison S; Crossley A; Park B; Lofts S; Lynch I; Vázquez-Campos S; Kaegi R; Gogos A; Asbach C; Cornelis G; von der Kammer F; van den Brink NW; Mays C; Spurgeon DJ
    Nat Nanotechnol; 2020 Sep; 15(9):731-742. PubMed ID: 32807878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European nanomaterial legislation in the past 20 years - Closing the final gaps.
    Nielsen MB; Skjolding L; Baun A; Hansen SF
    NanoImpact; 2023 Oct; 32():100487. PubMed ID: 37821007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations on the EU definition of a nanomaterial: science to support policy making.
    Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dealing with nanosafety around the globe-Regulation vs. innovation.
    Wacker MG; Proykova A; Santos GML
    Int J Pharm; 2016 Jul; 509(1-2):95-106. PubMed ID: 27184102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nanosafety studies of nanomaterials about biodistribution and immunotoxicity].
    Yoshioka Y
    Yakugaku Zasshi; 2011 Feb; 131(2):221-4. PubMed ID: 21297365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DaNa
    Krug HF; Bohmer N; Kühnel D; Marquardt C; Nau K; Steinbach C
    Nanomaterials (Basel); 2018 Mar; 8(4):. PubMed ID: 29596351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.